[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP2077262,2009,A1Locationinpatent:Page/Pagecolumn65
848501-94-0 | 2-Bromothiazole-4-carboxamide | AA004QQ6 | MFCD11870082
85081-18-1 | Nbi-98782 | AA004RNP | MFCD08061467
850568-01-3 | 2-Bromomethyl-4-fluorophenylboronic acid | AA004SFI | MFCD06659867
867034-10-4 | Ethyl 7-chloro-1h-pyrrolo[2,3-c]pyridine-2-carboxylate | AA004T9E | MFCD13184346
866546-11-4 | 1H-Pyrrolo[2,3-b]pyridine, 5-chloro-1-[(4-methylphenyl)sulfonyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) | AA004TUZ | MFCD16039195
855400-82-7 | 5-Bromo-4-chloro-2-nitrophenol | AA004UO9 | MFCD22383651
852180-38-2 | Methyl 5-(3-pyridinyloxy)-2-furoate | AA004VVT | MFCD07368496
83341-28-0 | 5-Fluoro-4-methyl-2-nitrophenol | AA004X6D | MFCD16658619
850623-44-8 | Potassium (2-benzyloxyphenyl)trifluoroborate | AA004YBT | MFCD04115742
799262-37-6 | 3-(5-Methyl-1H-tetrazol-1-yl)benzoic acid | AA004Z6I | MFCD04113966